scispace - formally typeset
K

Keisuke Horiuchi

Researcher at National Defense Medical College

Publications -  139
Citations -  5834

Keisuke Horiuchi is an academic researcher from National Defense Medical College. The author has contributed to research in topics: Ectodomain & Tumor necrosis factor alpha. The author has an hindex of 35, co-authored 132 publications receiving 4989 citations. Previous affiliations of Keisuke Horiuchi include Temple University & Kettering University.

Papers
More filters
Journal ArticleDOI

Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.

TL;DR: It is demonstrated that Adam17(fl/fl)Sox9-(Cre) mice, generated to model ADAM17-deficiency in human, developed eczematous dermatitis with naturally occurring dysbiosis, similar to that observed in atopic dermatitis.
Journal ArticleDOI

Cutting Edge: TNF-α-Converting Enzyme (TACE/ADAM17) Inactivation in Mouse Myeloid Cells Prevents Lethality from Endotoxin Shock

TL;DR: It is reported that TACE inactivation in myeloid cells or temporal inactivation at 6 wk offers strong protection from endotoxin shock lethality in mice by preventing increased TNF serum levels, further validating TACE as a principal target for the treatment of TNF-dependent pathologies.
Journal ArticleDOI

ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins Such as Transforming Growth Factor α, L-Selectin, and Tumor Necrosis Factor α

TL;DR: It is shown that Ca++ influx and stimulation of the P2X7R signaling pathway activate ADAM10 as sheddase of many ADAM17 substrates in Adam17-/- fibroblasts and primary B cells, which has general implications for understanding the substrate selectivity of two major cellular sheddases, ADAMs 10 and 17.